BIO-TECHNE Corp Financing Cash Flow
BIO-TECHNE Corp (TECH) reported Financing Cash Flow of -$169.11 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-24
- BIO-TECHNE Corp net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$33.21M.
- BIO-TECHNE Corp net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$42.72M.
- BIO-TECHNE Corp net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$48.99M.
- BIO-TECHNE Corp net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$44.20M.
- BIO-TECHNE Corp net cash provided by (used in) financing activities for fiscal 2026 was -$169.11M.
- BIO-TECHNE Corp net cash provided by (used in) financing activities for fiscal 2025 was -$253.91M.
- BIO-TECHNE Corp net cash provided by (used in) financing activities for fiscal 2024 was -$122.40M, a 641.20% decline from fiscal 2023.
- BIO-TECHNE Corp net cash provided by (used in) financing activities for fiscal 2023 was $22.62M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$33.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | -$75.92M derived: sum of 2 quarters · filed 2026-08-24 | -$124.91M derived: sum of 3 quarters · filed 2026-08-24 | -$169.11M 10-K · filed 2026-08-24 |
| 2026-03-31 | -$42.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | -$91.70M derived: sum of 2 quarters · filed 2026-05-06 | -$135.91M 10-Q · filed 2026-05-06 | -$226.36M derived: sum of 4 quarters · filed 2026-08-24 |
| 2025-12-31 | -$48.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | -$93.19M 10-Q · filed 2026-02-04 | -$183.64M derived: sum of 3 quarters · filed 2026-08-24 | -$251.69M derived: sum of 4 quarters · filed 2026-08-24 |
| 2025-09-30 | -$44.20M 10-Q · filed 2025-11-05 | -$134.66M derived: sum of 2 quarters · filed 2026-08-24 | -$202.70M derived: sum of 3 quarters · filed 2026-08-24 | -$286.54M derived: sum of 4 quarters · filed 2026-08-24 |
| 2025-06-30 | -$90.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | -$158.50M derived: sum of 2 quarters · filed 2026-08-24 | -$242.33M derived: sum of 3 quarters · filed 2026-08-24 | -$253.91M 10-K · filed 2026-08-24 |
| 2025-03-31 | -$68.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | -$151.88M derived: sum of 2 quarters · filed 2026-05-06 | -$163.45M 10-Q · filed 2026-05-06 | -$223.55M derived: sum of 4 quarters · filed 2026-08-24 |
| 2024-12-31 | -$83.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | -$95.41M 10-Q · filed 2026-02-04 | -$155.50M derived: sum of 3 quarters · filed 2026-08-24 | -$207.92M derived: sum of 4 quarters · filed 2026-08-24 |
| 2024-09-30 | -$11.57M 10-Q · filed 2025-11-05 | -$71.67M derived: sum of 2 quarters · filed 2026-08-24 | -$124.08M derived: sum of 3 quarters · filed 2026-08-24 | -$205.48M derived: sum of 4 quarters · filed 2026-08-24 |
| 2024-06-30 | -$60.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | -$112.51M derived: sum of 2 quarters · filed 2026-08-24 | -$193.91M derived: sum of 3 quarters · filed 2026-08-24 | -$122.40M 10-K · filed 2026-08-24 |
| 2024-03-31 | -$52.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-08 | -$133.81M derived: sum of 2 quarters · filed 2025-05-08 | -$62.30M 10-Q · filed 2025-05-08 | -$86.53M derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-12-31 | -$81.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-06 | -$9.89M 10-Q · filed 2025-02-06 | -$34.11M derived: sum of 3 quarters · filed 2025-08-22 | $116.73M derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-09-30 | $71.51M 10-Q · filed 2024-11-05 | $47.29M derived: sum of 2 quarters · filed 2025-08-22 | $198.13M derived: sum of 3 quarters · filed 2025-08-22 | $125.93M derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-06-30 | -$24.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $126.62M derived: sum of 2 quarters · filed 2025-08-22 | $54.42M derived: sum of 3 quarters · filed 2025-08-22 | $22.62M 10-K · filed 2025-08-22 |
| 2023-03-31 | $150.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-06 | $78.64M derived: sum of 2 quarters · filed 2024-05-06 | $46.84M 10-Q · filed 2024-05-06 | -$18.89M derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-12-31 | -$72.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-07 | -$104.00M 10-Q · filed 2024-02-07 | -$169.73M derived: sum of 3 quarters · filed 2024-08-22 | -$253.79M derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-09-30 | -$31.81M 10-Q · filed 2023-11-07 | -$97.53M derived: sum of 2 quarters · filed 2024-08-22 | -$181.60M derived: sum of 3 quarters · filed 2024-08-22 | -$234.97M derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-06-30 | -$65.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | -$149.79M derived: sum of 2 quarters · filed 2024-08-22 | -$203.17M derived: sum of 3 quarters · filed 2024-08-22 | -$242.85M 10-K · filed 2024-08-22 |
| 2022-03-31 | -$84.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-08 | -$137.44M derived: sum of 2 quarters · filed 2023-05-08 | -$177.13M 10-Q · filed 2023-05-08 | -$59.44M derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-12-31 | -$53.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | -$93.06M 10-Q · filed 2023-02-07 | $24.63M derived: sum of 3 quarters · filed 2023-08-23 | -$30.60M derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-09-30 | -$39.68M 10-Q · filed 2022-11-07 | $78.00M derived: sum of 2 quarters · filed 2023-08-23 | $22.78M derived: sum of 3 quarters · filed 2023-08-23 | -$67.30M derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-06-30 | $117.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $62.46M derived: sum of 2 quarters · filed 2023-08-23 | -$27.62M derived: sum of 3 quarters · filed 2023-08-23 | -$62.55M 10-K · filed 2023-08-23 |
| 2021-03-31 | -$55.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-09 | -$145.31M derived: sum of 2 quarters · filed 2022-05-09 | -$180.24M 10-Q · filed 2022-05-09 | -$224.96M derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-12-31 | -$90.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-07 | -$125.01M 10-Q · filed 2022-02-07 | -$169.73M derived: sum of 3 quarters · filed 2022-08-24 | -$187.52M derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-09-30 | -$34.93M 10-Q · filed 2021-11-08 | -$34.93M 10-Q · filed 2020-11-09 | -$97.44M derived: sum of 3 quarters · filed 2022-08-24 | -$194.47M derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-06-30 | -$44.72M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | -$62.51M derived: sum of 2 quarters · filed 2022-08-24 | -$159.53M derived: sum of 3 quarters · filed 2022-08-24 | -$183.80M 10-K · filed 2022-08-24 |
| 2020-03-31 | -$17.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-07 | -$114.81M derived: sum of 2 quarters · filed 2021-05-07 | -$139.08M 10-Q · filed 2021-05-07 | -$158.98M derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-12-31 | -$97.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08 | -$121.30M 10-Q · filed 2021-02-08 | -$141.19M derived: sum of 3 quarters · filed 2021-08-25 | -$168.24M derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-09-30 | -$24.27M 10-Q · filed 2019-11-06 | -$24.27M 10-Q · filed 2020-11-09 | -$71.21M derived: sum of 3 quarters · filed 2021-08-25 | -$112.42M derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-06-30 | -$19.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | -$46.94M derived: sum of 2 quarters · filed 2021-08-25 | -$88.15M derived: sum of 3 quarters · filed 2021-08-25 | $134.38M 10-K · filed 2021-08-25 |
| 2019-03-31 | -$27.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | -$68.25M derived: sum of 2 quarters · filed 2020-05-11 | $154.28M 10-Q · filed 2020-05-11 | $91.45M derived: sum of 4 quarters · filed 2020-08-26 |
| 2018-12-31 | -$41.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | $181.32M 10-Q · filed 2020-02-06 | $118.49M derived: sum of 3 quarters · filed 2020-08-26 | $117.54M derived: sum of 4 quarters · filed 2020-08-26 |
| 2018-09-30 | $222.53M 10-Q · filed 2019-11-06 | $159.70M derived: sum of 2 quarters · filed 2020-08-26 | $158.75M derived: sum of 3 quarters · filed 2020-08-26 | $174.30M derived: sum of 4 quarters · filed 2020-08-26 |
| 2018-06-30 | -$62.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | -$63.78M derived: sum of 2 quarters · filed 2020-08-26 | -$48.23M derived: sum of 3 quarters · filed 2020-08-26 | -$99.19M 10-K · filed 2020-08-26 |
| 2018-03-31 | -$952.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-07 | $14.60M derived: sum of 2 quarters · filed 2019-05-07 | -$36.36M 10-Q · filed 2019-05-07 | -$53.00M derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-12-31 | $15.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | -$35.40M 10-Q · filed 2019-02-07 | -$52.05M derived: sum of 3 quarters · filed 2019-11-06 | -$76.57M derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-09-30 | -$50.95M 10-Q · filed 2018-11-07 | -$67.60M derived: sum of 2 quarters · filed 2019-11-06 | -$50.95M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$16.64M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | -$41.16M derived: sum of 2 quarters · filed 2019-11-06 | $189.11M 10-K/A · filed 2019-11-06 | |
| 2017-03-31 | -$24.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $205.76M 10-Q · filed 2018-05-09 | ||
| 2016-12-31 | $230.28M 10-Q · filed 2018-02-08 | |||
| 2016-09-30 | $242.16M 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | -$23.37M 10-K · filed 2018-08-27 | |||
| 2014-03-31 | -$9.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | -$18.89M derived: sum of 2 quarters · filed 2014-05-12 | -$28.80M 10-Q · filed 2014-05-12 | -$41.38M derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-12-31 | -$8.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-04 | -$18.89M 10-Q · filed 2014-02-04 | -$31.47M derived: sum of 3 quarters · filed 2014-02-04 | -$42.52M derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-09-30 | -$9.90M 10-Q · filed 2013-11-12 | -$22.49M derived: sum of 2 quarters · filed 2013-11-12 | -$33.53M derived: sum of 3 quarters · filed 2014-05-12 | -$43.83M derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-06-30 | -$12.58M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | -$23.63M derived: sum of 2 quarters · filed 2014-05-12 | -$33.93M derived: sum of 3 quarters · filed 2014-05-12 | -$44.68M 10-K · filed 2013-08-29 |
| 2013-03-31 | -$11.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | -$21.34M derived: sum of 2 quarters · filed 2014-05-12 | -$32.09M 10-Q · filed 2014-05-12 | -$44.54M derived: sum of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | -$10.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-04 | -$21.05M 10-Q · filed 2014-02-04 | -$33.49M derived: sum of 3 quarters · filed 2014-02-04 | -$46.69M derived: sum of 4 quarters · filed 2014-02-04 |
| 2012-09-30 | -$10.75M 10-Q · filed 2013-11-12 | -$23.19M derived: sum of 2 quarters · filed 2013-11-12 | -$36.39M derived: sum of 3 quarters · filed 2013-11-12 | -$53.82M derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-06-30 | -$12.45M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | -$25.64M derived: sum of 2 quarters · filed 2013-08-29 | -$43.07M derived: sum of 3 quarters · filed 2013-08-29 | -$64.63M 10-K · filed 2013-08-29 |
| 2012-03-31 | -$13.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-10 | -$30.62M derived: sum of 2 quarters · filed 2013-05-10 | -$52.18M 10-Q · filed 2013-05-10 | -$60.42M derived: sum of 4 quarters · filed 2013-08-29 |
| 2011-12-31 | -$17.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-11 | -$38.98M 10-Q · filed 2013-02-11 | -$47.22M derived: sum of 3 quarters · filed 2013-08-29 | -$57.24M derived: sum of 4 quarters · filed 2013-08-29 |
| 2011-09-30 | -$21.56M 10-Q · filed 2012-11-09 | -$29.80M derived: sum of 2 quarters · filed 2013-08-29 | -$39.81M derived: sum of 3 quarters · filed 2013-08-29 | -$46.93M derived: sum of 4 quarters · filed 2013-08-29 |
| 2011-06-30 | -$8.24M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | -$18.26M derived: sum of 2 quarters · filed 2013-08-29 | -$25.38M derived: sum of 3 quarters · filed 2013-08-29 | -$36.29M 10-K · filed 2013-08-29 |
| 2011-03-31 | -$10.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-10 | -$17.14M derived: sum of 2 quarters · filed 2012-05-10 | -$28.05M 10-Q · filed 2012-05-10 | -$51.08M derived: sum of 4 quarters · filed 2012-08-29 |
| 2010-12-31 | -$7.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-07 | -$18.03M 10-Q · filed 2012-02-07 | -$41.06M derived: sum of 3 quarters · filed 2012-08-29 | -$49.63M derived: sum of 4 quarters · filed 2012-08-29 |
| 2010-09-30 | -$10.91M 10-Q · filed 2011-11-09 | -$33.94M derived: sum of 2 quarters · filed 2012-08-29 | -$42.51M derived: sum of 3 quarters · filed 2012-08-29 | -$51.54M derived: sum of 4 quarters · filed 2012-08-29 |
| 2010-06-30 | -$23.03M derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-29 | -$31.59M derived: sum of 2 quarters · filed 2012-08-29 | -$40.63M derived: sum of 3 quarters · filed 2012-08-29 | -$50.51M 10-K · filed 2012-08-29 |
| 2010-03-31 | -$8.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-05-10 | -$17.60M derived: sum of 2 quarters · filed 2011-05-10 | -$27.48M 10-Q · filed 2011-05-10 | |
| 2009-12-31 | -$9.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-02-09 | -$18.92M 10-Q · filed 2011-02-09 | ||
| 2009-09-30 | -$9.89M 10-Q · filed 2010-11-09 | |||
| 2009-06-30 | -$119.44M 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |